XML 69 R52.htm IDEA: XBRL DOCUMENT
v3.24.1

Research and License Agreements (Details) - Apollomics, Inc. - USD ($) $ in Millions |  | 3 Months Ended | 12 Months Ended
--- | --- | --- | ---
Dec. 30, 2021 | Mar. 31, 2020 | Dec. 31, 2023 | Dec. 31, 2022
Research and License Agreements |  |  |  |
Revenue from sale of clinical supplies | $ 1.1 |  | $ 0.0 | $ 0.0
Up-front payment received |  | $ 9.0 |  |
Maximum |  |  |  |
Research and License Agreements |  |  |  |
Milestones based on achievement of certain clinical and regulatory events |  | 75.0 |  |
Milestone payment upon achievement of specified net sales thresholds for all licensed products |  | $ 105.0 |  |
Tiered percentage of annual net sales |  | 15.00% |  |

X
- Definition The amount of revenue to be received upon the achievement of specified net sales thresholds for all licensed products. + References No definition available. + Details
Name: | glyc_AchievementOfSpecifiedNetSalesThresholdsForAllLicensedProducts
Namespace Prefix: | glyc_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | glyc_ArrangementsAndNonarrangementTransactionsLineItems
Namespace Prefix: | glyc_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of development and regulatory specific approval milestones based on achievement of certain clinical and regulatory events. + References No definition available. + Details
Name: | glyc_DevelopmentAndRegulatoryApprovalMilestonesClinicalAndRegulatoryEvents
Namespace Prefix: | glyc_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount of revenue from the sale of clinical supplies. + References No definition available. + Details
Name: | glyc_RevenueReceivedFromSaleOfClinicalSupplies
Namespace Prefix: | glyc_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The entitled royalty payments to be received based on a tiered percentage of annual net sales. + References No definition available. + Details
Name: | glyc_TieredPercentageOfAnnualNetSales
Namespace Prefix: | glyc_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of up-front payment received under terms of the agreement. + References No definition available. + Details
Name: | glyc_UpFrontPaymentReceived
Namespace Prefix: | glyc_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | srt_CounterpartyNameAxis=glyc_ApollomicMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |